Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd. is an innovative biopharmaceutical company listed on the ChiNext board of the Shenzhen Stock Exchange since 2011. The company focuses on the research, development, manufacturing, and marketing of innovative drugs, particularly in the fields of protein drugs, gene drugs, and chemical drugs. Staidson's primary therapeutic areas include diseases of the nervous system, infectious diseases, gastrointestinal diseases, urological diseases, and autoimmune diseases. The company's notable products include Su Tai Sheng, a nerve growth factor injection that promotes recovery from optic nerve injuries, and Freecol, a polyethylene glycol electrolyte powder used for bowel cleansing. Staidson also offers Shu Wei Xin, a trospium chloride capsule for overactive bladder treatment. With a strong emphasis on continuous innovation and a robust portfolio of research programs, Staidson aims to contribute to human health while maintaining its position as a leader in the biopharmaceutical industry in China.

Innovative research and development. Our mission is to "continue to innovate, provide safe and effective treatment drugs and make contribution to human health". We attach great importance to the continuous innovation of products and technologies. Staidson has been recognized as innovative pilot projects of Beijing High-tech Enterprises and Zhongguancun National Independent Innovation Demonstration Zone Enterprise, and the advanced scientific and technological innovation unit of Beijing Economic and Technological Development Zone. Advantage of product brand. The main product of our company, Su Tai Sheng, is the first drug to be certificated in China in the field of nerve growth factor candidates, and the first drug to finish phrase IV clinical experiments after getting the certificate to sale. In order to expand the clinical application of Su Tai Sheng, Staidson applied and received the clinical approval for the new indications of "diabetic foot" and "traumatic peripheral nerve injury" in 2016 respectively. As another internationally recognized leading product, freecol is the first-line candidate in the field of Ethylene glycol products, ranking the first in the market of bowel cleansing. Advantages in Corporate culture and human resources. We have a stable and cohesive team with rich management experience and many years of experience in biopharmaceutical industry, which has a common understanding and solid pursuit to develop, produce and sell "safe and effective therapeutic drugs".